Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001295

Pres. Research & Development bought 1,786 shares at $2.57 ($4,590)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young David Pres. Research & Development 2026-05-29 Purchase +1,786 $2.57 $4,590 17,131 D
Open-market purchases · 1,786 sh · avg $2.57 · $4,590
Loading xslF345X06/form4.xml…